Differences

This shows you the differences between two versions of the page.

--- md_biochemistry [2026/06/26 13:14]
admin
+++ md_biochemistry [2026/09/22 06:19] (current)
resident
@@ Line 26: / Line 26: @@
 |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} |
 |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}|
-|23|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}|
+|24|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}|
-|24|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL-133|
+|25|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL - 133|{{ ::use_and_implementation_of_nabl_symbol_as_per_nabl_-_133_in_medical_testing_laboratories.pptx |Use and Implementation of NABL Symbol as per NABL - 133 in Medical Testing Laboratories}}|
-|25|:::| |
+|26|:::|FTIR|{{ ::ftir.pptx |FTIR-Principle}}|
-|26|:::| |
+|27|:::|Quality Policy vs Quality Objective|{{ ::quality_policy_vs_quality_objective_in_context_of_iso_151892022.pptx |Quality Policy vs Quality Objective in Context of ISO 151892022}}|
-|27|:::| |
+|28|:::|VLDL Metabolism|{{ ::vldl_metabolism.pptx |VLDL Metabolism}}|
-|28|:::| |
+|29|:::|D-Dimer|{{ ::d-dimer.pptx |D-Dimer}}|
-|29|:::| |
 |30|:::| |
 |31|:::| |
-|24|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|
+|32|:::| |
-|25|:::| |
+|33|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|
-|26|:::| |
+|34|:::| |
+|35|:::| |
 |27|:::| |
 |28|:::| |
@@ Line 49: / Line 49: @@
 |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}|
 |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}|
-|30|:::| |
+|30|:::|Risk factor of Atherosclerosis |{{ ::risk_factors_for_atherosclerosis_1_.pptx |}} |
-|31|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | |
+|31|:::|Prevention of Atherosclerosis |{{ ::prevention_of_atherosclerosis.pptx |}} |
-|31|<html><span style="font-size:150%;">Dr Shivam</span></html> | |
+|32|:::|Little Rascal - Lipoprotein-a |{{ ::lipoprotein_a_1_.pptx |}} |
+|33|:::|Mitochondrial DNA |{{ ::mitochondrial_dna.pptx |}} |
+|34|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | |
+|35|<html><span style="font-size:150%;">Dr Shivam</span></html> | |
 =====Model Questions List For MD Biochemistry=====
@@ Line 123: / Line 126: @@
   - ''Molar absorptivity of NADh and calculation of enzyme factors''
   - ''Biochemical explanation of pulmonary embolism in deep sea divers''
+  - ''Requirement as per ISO 15189:2022 for POCT.''
@@ Line 193: / Line 198: @@
   - ATP IV Hypercholesterolemia diagnostic guidline
   - beta thalassemia – genetics, pathogenesis, diagnosis
+  - ''Define tertiary structure of protein with domain and chaperon. Explain pathogenesis of prion disease with example of amyloidosis.''
+  - ''Enumerate cholesterol synthesis with regulation. Describe type of dyslipidemia. Explain framingham risk scores for cardiovascular risk.''
+  - ''Metabolic and neuro-transmitter alteration during alcohol addiction and withdrawal.''
+  - ''Classify obesity. Explain endocrinal pathogenesis of obesity.''
+  - ''Function and significant of PTH and Intact PTH.''
+  - ''Effect of cirrhosis of liver on metabolism and  digestion – absorption''
+  - ''Genetic regulation of haemoglobin synthesis and impact of therapeutic drugs & metal on it.''
+  - ''Explain “Role of vitamins on metabolism” (with examples)''
+  - ''Alteration in blood buffer and renal buffer in case of extensive interstitial lung disease.''
 |<html> <span style="color:   #700800   ;font-size:125%;">2024</span> </html>|<html> <span style="color:   #700800   ;font-size:125%;">List of Model Question for Paper-3 - Molecular Biology , Immunology and Cancer</span> </html>|
@@ Line 224: / Line 242: @@
   - Write note somatic hyper mutation and iso-type switching of immunoglobin.
   - Regulation of m-RNA stability
+  - ''Type and significance of all the type of RNA. Clinical co-relation of RNA in pathogenesis of cancer , atherosclerosis and Age related Macular Degeneration (AMD)''
+  - ''Viral integration and transposons in human genome. Molecular impact of anti-viral drugs - Acylovir.''
+  - ''Regulation of eukaryotic gene expression''
+  - ''Journey of human genome evolution from mutation to substitution.''
+  - ''Tumor Supressor Gene - BRCA and p53''
+  - ''Meiosis vs Mitosis''
+  - ''Molecular defect in cystic fibrosis''
+  - ''Quantitative Real time PCR''
+  - ''DNA dependent DNA polymerase and DNA ligase.''
 |<html> <span style="color:   #700800   ;font-size:125%;">2024</span> </html>|<html> <span style="color:   #700800   ;font-size:125%;">List of Model Question for Paper-4 - Technique in experimental biochemistry , Recent advances</span> </html>|
@@ Line 305: / Line 336: @@
   - Write performance validation protocol for these specified resource ( instrument / reagent / consumable)
   - Write a consistent quality policy and objective with defined quality indicator, for your laboratory.
+  - ''Enumerate analytical methods with it’s principle , significant and limitation of creatinine estimation and eGFR.''
+  - ''Definition of quality indicator with it’s standard requirements. Define quality indicator for period of sample collection to sample receipt (minimum four QI ) and sample storage (minimum four QI ) with process of it’s monitoring and measuring elements.''
+  - ''Principle and utility of Fourier Transform Infrared (FTIR) spectroscopy in clinical biochemistry laboratory. Approach to validate the result of FTIR.''
+  - ''Structure and component of “Foundation Course” for First year Indian Medical Graduate (IMG)''
+  - ''AETCOM''
+  - ''Document Control and Control of Record as per ISO 15189:2022''
+  - ''Use of moving average of patient data as IQC alternative''
+  - ''Delta Bilirubin - Define and Clinical significant.''
+  - ''Component and Principle of Flame Photometer''
+  - ''Mechanism , clinical utility and biochemical adverse event with use of GLP-1 analogues''
+  - ''Sample acceptance exception in case of wrong vacuette (Write minimum 4 scenario)''
 |<html> <span style="color:   #700800   ;font-size:125%;">2024</span> </html>|<html> <span style="color:   #700800   ;font-size:125%;">Drugs To Read With Biochemical Mechanism</span> </html>|